488 related articles for article (PubMed ID: 24163075)
1. Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.
McCarthy CG; Goulopoulou S; Wenceslau CF; Spitler K; Matsumoto T; Webb RC
Am J Physiol Heart Circ Physiol; 2014 Jan; 306(2):H184-96. PubMed ID: 24163075
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity in hypertension.
Mian MO; Paradis P; Schiffrin EL
Curr Hypertens Rep; 2014 Feb; 16(2):413. PubMed ID: 24407446
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor activation, vascular endothelial function, and hypertensive disorders of pregnancy.
Balasubbramanian D; Gelston CAL; Mitchell BM; Chatterjee P
Pharmacol Res; 2017 Jul; 121():14-21. PubMed ID: 28419848
[TBL] [Abstract][Full Text] [Related]
4. Are the innate and adaptive immune systems setting hypertension on fire?
Bomfim GF; Rodrigues FL; Carneiro FS
Pharmacol Res; 2017 Mar; 117():377-393. PubMed ID: 28093357
[TBL] [Abstract][Full Text] [Related]
5. Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats.
McCarthy CG; Wenceslau CF; Goulopoulou S; Ogbi S; Baban B; Sullivan JC; Matsumoto T; Webb RC
Cardiovasc Res; 2015 Jul; 107(1):119-30. PubMed ID: 25910936
[TBL] [Abstract][Full Text] [Related]
6. Toll-Like Receptors in the Pathogenesis of Essential Hypertension. A Forthcoming Immune-Driven Theory in Full Effect.
Lazaridis A; Gavriilaki E; Douma S; Gkaliagkousi E
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810594
[TBL] [Abstract][Full Text] [Related]
7. Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension.
Sollinger D; Eißler R; Lorenz S; Strand S; Chmielewski S; Aoqui C; Schmaderer C; Bluyssen H; Zicha J; Witzke O; Scherer E; Lutz J; Heemann U; Baumann M
Cardiovasc Res; 2014 Mar; 101(3):464-72. PubMed ID: 24302630
[TBL] [Abstract][Full Text] [Related]
8. Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.
Loppnow H; Buerke M; Werdan K; Rose-John S
J Cell Mol Med; 2011 Mar; 15(3):484-500. PubMed ID: 21199323
[TBL] [Abstract][Full Text] [Related]
9. Paying the Toll for Inflammation.
McCarthy CG; Goulopoulou S; Webb RC
Hypertension; 2019 Mar; 73(3):514-521. PubMed ID: 30661480
[No Abstract] [Full Text] [Related]
10. DAMPening inflammation by modulating TLR signalling.
Piccinini AM; Midwood KS
Mediators Inflamm; 2010; 2010():. PubMed ID: 20706656
[TBL] [Abstract][Full Text] [Related]
11. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
Goulopoulou S; McCarthy CG; Webb RC
Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
[TBL] [Abstract][Full Text] [Related]
12. Innate immunity in systemic sclerosis pathogenesis.
O'Reilly S
Clin Sci (Lond); 2014 Mar; 126(5):329-37. PubMed ID: 24219159
[TBL] [Abstract][Full Text] [Related]
13. The innate immune response in reperfused myocardium.
Timmers L; Pasterkamp G; de Hoog VC; Arslan F; Appelman Y; de Kleijn DP
Cardiovasc Res; 2012 May; 94(2):276-83. PubMed ID: 22266751
[TBL] [Abstract][Full Text] [Related]
14. The innate immune system, toll-like receptors and dermal wound healing: A review.
Portou MJ; Baker D; Abraham D; Tsui J
Vascul Pharmacol; 2015 Aug; 71():31-6. PubMed ID: 25869514
[TBL] [Abstract][Full Text] [Related]
15. The toll of the gridiron: damage-associated molecular patterns and hypertension in American football.
McCarthy CG; Webb RC
FASEB J; 2016 Jan; 30(1):34-40. PubMed ID: 26316270
[TBL] [Abstract][Full Text] [Related]
16. Inflammasomes in Tissue Damages and Immune Disorders After Trauma.
Bortolotti P; Faure E; Kipnis E
Front Immunol; 2018; 9():1900. PubMed ID: 30166988
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial cell Toll-like receptor pathways in sepsis.
Khakpour S; Wilhelmsen K; Hellman J
Innate Immun; 2015 Nov; 21(8):827-46. PubMed ID: 26403174
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
19. Self, non-self, and danger: a complementary view.
Köhl J
Adv Exp Med Biol; 2006; 586():71-94. PubMed ID: 16893066
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Innate Immune Receptors: Guardians of the Micro Galaxy : Activation and Functions of the Innate Immune Receptors.
De Nardo D
Adv Exp Med Biol; 2017; 1024():1-35. PubMed ID: 28921463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
